Researchers have announced that Health Canada has licensed new software for the MiniMed™ 780G insulin delivery system, enhancing diabetes care for adults with Type 2 diabetes. This updated system features Meal Detection™ technology and SmartGuard™, which automatically adjusts insulin delivery based on real-time glucose levels. The new Simplera Sync™ sensor, which requires no fingersticks and is easier to insert, promises a more comfortable experience for users.

This development is significant for people managing diabetes, as it could lead to better glucose control and less daily hassle. The MiniMed™ 780G system has shown that users can achieve over 80% of their time in a healthy glucose range when using optimal settings. For adults with Type 2 diabetes, this means potentially fewer complications related to blood sugar spikes and drops, allowing them to focus on their daily lives rather than constant monitoring.

The evidence supporting this system comes from extensive clinical trials and real-world usage, indicating strong effectiveness in managing glucose levels. While the technology has been proven beneficial for many individuals with Type 1 diabetes, the new software’s impact on Type 2 diabetes patients is still being evaluated. As this system rolls out in Canada, it represents a promising advancement in diabetes management, but users should remain engaged with their healthcare providers to tailor the system to their specific needs.

Source: globenewswire.com